Algemeen Ziekenhuis Groeninge

At Algemeen Ziekenhuis Groeninge, research in nutritional and metabolic diseases focuses on conditions such as type 2 diabetes mellitus, obesity, chronic weight management, and metabolic dysfunction-associated steatotic liver disease. These studies aim to improve long-term disease control, support healthier metabolism, and evaluate new treatment strategies for common chronic conditions.

• Studies exploring better ways to manage diabetes and related metabolic complications
• Research on obesity and weight-related health risks
• Trials assessing treatments for fatty liver disease and broader metabolic health

The site’s work in this area is centered on improving everyday care for patients with chronic metabolic disorders through safer and more effective therapies.

A major focus at this hospital is cardiovascular disease and kidney disease, including atherosclerotic cardiovascular disease, heart failure, hypertension, calcific aortic valve stenosis, and chronic kidney disease. The trials in this field are designed to test new options that may lower cardiovascular risk, slow kidney decline, and improve outcomes for people with overlapping heart and kidney conditions.

• Studies on preventing major heart and blood vessel events in atherosclerotic cardiovascular disease
• Trials for heart failure and related symptoms
• Research aimed at slowing chronic kidney disease progression and protecting kidney function

This research area also includes work on lipoprotein(a) and other risk factors that may help refine prevention and treatment strategies.

The largest share of studies at Algemeen Ziekenhuis Groeninge involves neoplasms and hemic and lymphatic diseases. Research covers prostate cancer, breast cancer, lung cancer, colorectal cancer, melanoma, pancreatic cancer, bladder cancer, ovarian cancer, and blood cancers such as multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma. These trials often aim to improve survival, delay progression, and identify more effective treatment combinations.

• Studies testing new approaches for advanced and metastatic solid tumors
• Trials focused on prostate cancer, including metastatic and castration-resistant disease
• Research in breast cancer, lung cancer, and gastrointestinal cancers

The site also contributes to studies in hematologic malignancies, where the goal is to improve disease control and long-term outcomes for patients with harder-to-treat blood cancers.

Clinical research at the site includes digestive system diseases, immune system diseases, and bacterial and virus diseases. Key conditions include Crohn’s disease, ulcerative colitis, eosinophilic esophagitis, chronic hepatitis B infection, and severe respiratory infections. These trials are designed to improve symptom control, prevent complications, and evaluate more targeted treatment options.

• Studies on inflammatory bowel disease to reduce disease activity and recurrence
• Research on eosinophilic esophagitis and related immune-driven inflammation
• Trials in infectious diseases and severe infection management

This area reflects a strong interest in treatments that can better control inflammation while supporting long-term digestive health.

The site also participates in studies involving nervous system diseases and mental disorders, including Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, migraine, psychosis associated with Alzheimer’s disease, and chronic pain. Research in this field aims to improve early detection, slow cognitive decline, reduce symptoms, and support better quality of life.

• Trials evaluating therapies for Alzheimer’s disease and mild cognitive impairment
• Studies in multiple sclerosis and other neurological disorders
• Research on migraine and chronic low back pain to improve symptom relief

These studies combine clinical care goals with a focus on preserving function and daily independence for patients affected by neurological and pain-related conditions.

Additional trials at Algemeen Ziekenhuis Groeninge span respiratory tract diseases, musculoskeletal diseases, and selected pathological conditions. This includes asthma, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, rheumatoid arthritis, and persistent spinal pain syndrome. The purpose of these studies is to test new therapies, improve symptom control, and better understand disease progression in chronic conditions.

• Research on asthma and other chronic lung disorders
• Studies in idiopathic pulmonary fibrosis and severe respiratory disease
• Trials for rheumatoid arthritis and other musculoskeletal pain conditions

Together, these studies show a broad clinical research portfolio that extends beyond one specialty and supports innovation across multiple chronic disease areas.